Novel CA-125 antigen determination in serum by electrochemical methods with onion oil-containing organo-hydrogels
Abstract
CA-125 antigen is a glycoprotein that can be found at distinct levels in blood samples according to the phases of ovarian cancer. Herein, we designed novel onion oil-organo-hydrogels (OOHGs) to detect CA-125 antigen at high sensitivity and selectively via electrochemical methods. OOHGs produced are characterized by swelling analysis and Fourier Transform Infrared Spectroscopy (FT-IR). Cyclic voltammetry (CV), Electro impedance spectroscopy (EIS), and Differential pulse voltammetry (DPV) techniques in the potentiostat triple electron system are used for performing the electrochemical measurements. Performances and electron transfer resistances of OOHGs and OOHG+CA-125s are researched via CV and EIS, and the sensitivity properties such as LOD and LOQ of the sensor are determined via DPV. OOHG-2 among OOHGs produced exhibited the highest performance with 0.8151 mA/cm2 (815.1 A/cm2) value at determining CA-125 in serum medium. Moreover, this electrode is found that exhibit a wide linear range like a 1-500 ng/mL concentration range. The limit of quantification (LOQ) and the lowest of detection (LOD) for the OOHG-2 electrode are calculated as 0.531 U/mL and 0.265 U/mL (S/N=3), respectively. Further, the CA-125 antigen of the OOHG-2 electrode in interference results is observed that can be detected with high selectivity. With these results, it can be noted that the OOHG-2 electrode holds great hope for detection ovarian cancer by electrochemical methods.
Keywords
MBA, onion oil, electrochemical sensor, CA-125, ovarian cancer
References
- Kulasingam V., Diamandis EP., Strategies for discovering novel cancer biomarkers through utilization of emerging technologies, Nature clinical practice Oncology, 5, (2008), 588-99.
- Hayes D.F., Bast R.C., Desch C.E., Fritsche Jr.H., Kemeny N.E., Jessup J.M., Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers, Journal of the National Cancer Institute, 88, (1996), 1456-66.
- Duffy M., Clinical uses of tumor markers: a critical review, Critical reviews in clinical laboratory sciences, 38, (2001), 225-62.
- Duffy M.J., Tumor markers in clinical practice: a review focusing on common solid cancers, Medical Principles and Practice, 22, (2013), 4-11.
- Chikkaveeraiah B.V., Bhirde A.A., Morgan N.Y., Eden H.S., Chen X., Electrochemical immunosensors for detection of cancer protein biomarkers, ACS nano, 6, (2012), 6546-61.
- Wulfkuhle J.D., Liotta L.A., Petricoin E.F., Proteomic applications for the early detection of cancer, Nature reviews cancer, 3, (2003), 267-75.
- Kingsmore S.F., Multiplexed protein measurement: technologies and applications of protein and antibody arrays, Nature reviews Drug discovery, 5, (2006), 310-21.
- Reid B.M., Permuth J.B., Sellers T.A., Epidemiology of ovarian cancer: a review, Cancer biology & medicine, 14, (2017), 9.
- Majd S.M., Salimi A., Ultrasensitive flexible FET-type aptasensor for CA 125 cancer marker detection based on carboxylated multiwalled carbon nanotubes immobilized onto reduced graphene oxide film, Analytica chimica acta, 1000, (2018), 273-82.
- Diaconu I., Cristea C., Hârceagă V., Marrazza G., Berindan-Neagoe I., Săndulescu R., Electrochemical immunosensors in breast and ovarian cancer, Clinica Chimica Acta, 425, (2013), 128-38.